Isoetharine was administered intravenously in doses ranging from 1 to 15 /<g/kg to fourteen patients undergoing elective surgery during cyclopropane anaesthesia. In all cases isoetharine caused a decrease in systolic and diastolic arterial pressures and an increase in heart rate. These effects were dose-related, with a dose response plateau occurring between 5 and 10 ^g/kg. Variable displacement of the cardiac pacemaker to the AV node occurred. However, in no instances did premature ventricular contractions appear. It is concluded that isoetharine is a safe drug to be administered intravenously during inhalation anaesthesia with cyclopropane.
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Isoetharine is a catecholamine that is a structural analogue of isoproterenol. Figure 1 shows the structural similarities and differences between these two compounds.
Previous studies on animals have shown this compound to possess beta catecholamine receptor stimulating activity (Hoppe and Lape). These studies have shown that isoetharine produces bronchodilatation and antagonizes histamine-induced bronchoconstriction (Lands et al., 1950) . Other studies have shown that isoetharine produces an increase in heart rate and an increase in the force of contraction of the heart (Lands, Groblewski and Brown, 1966) . Isoetharine also inhibits smooth muscle contraction in the gut (Hoppe and Lape). This material has been used clinically over the past several years as a bronchodilator by topical administration to the respiratory tract (Unger and Unger, 1967) .* A recent study has shown that isoetharine could be administered intravenously to dogs during cyclopropane anaesthesia without producing ventricular arrhythmias (Shulman) . Since it would be of value to have available a potent, rapidly acting bronchodilator that could be administered intravenously with safety during inhalation anaesthesia with agents such as cyclopropane or halothane, the question was raised whether isoetharine might not fulfil this need.
• Dilabron fBreon): this preparation consists of a mixture of isoetharine 1.0 per cent, phenylephrine 0.25 per cent, and thenyldiamine 0.10 per cent. 
MATERIALS AND METHODS
Fourteen adult surgical patients undergoing elective surgery were selected for this study. Selection was made on the basis of a negative history of pre-existing cardiovascular disease and a normal pre-operative electrocardiogram. Table I shows the distribution of these patients according to age, race, sex, operative procedure, and premedication. In all cases, anaesthesia was induced with thiopentone given intravenously, and then maintained with cyclopropane and oxygen. Arterial blood pressure was determined by auscultation in all except one patient. In this latter patient (No. 12) it was determined by a Statham P23 db transducer connected to an intra-arterial catheter and recorded on a Gilson polygraph. Auscultatory measurements were made on either arm, but the same arm was used for all measurements in any given patient. The same observer made all of these measurements. In addition, standard lead two of the electrocardiogram was recorded on a Gilson polygraph.
Once stable readings of blood pressure and pulse were obtained, isoetharine was administered intravenously in doses of 1 to 15 iAg/kg, according to the following dosage schedule: patients 1-5 each received doses of 1, 2, 3, 4 and 5 ^g/kg, with the 1 ng/kg dose being given first, followed by each succeeding larger dose. Following each dose, the arterial blood pressure and pulse values were allowed to return to control or otherwise stable levels for at least 5 minutes before the next dose was given. Patients 6-9 each received a dose of 10 [Ag/kg only. Patient 10 received doses of 10 and 15 jj.g/kg. Following the 10 ng/kg dose, blood pressure and pulse readings were allowed to return to pre-injection values and remain there for 5 minutes before administering the 15 ,j.g/kg dose. Patients 11-14 received 15 i^g/kg only.
Following each dose, arterial Wood pressure was measured every 20 seconds until these readings became stable. Changes in pulse rate were determined by pyamming the continuous electrocardiograph record.
In all cases the definite surgical procedure was in progress while the measurements were being made. 
FIG. 2
Mean values for pulse rate and blood pressure (mm Hg) obtained after infusion of isoetharine. Recovery values are not shown. See "materials and methods" section of text for explanation of dosage schedule.
RESULTS
Changes in systolic and diastolic arterial pressure and heart rate following each dose are shown in table II. Figure 2 shows these results summarized in graphic form. It can be seen that there was a reduction in both systolic and the diastolic pressures, the pulse pressure remaining essentially unchanged. This effect seemed to reach a plateau at a dose of 5 ^g/kg. Heart rate was increased and this effect seemed to reach a plateau somewhere between 5 and 10 (Ag/kg. Hectrocardiographic findings are summarized in table HI. Electrocardiograms of seven of the fourteen patients showed sinus rhythm at all times. The rest of the patients showed either occasional nodal beats, sinus nodal coupling or nodal rhythm following various doses of isoetharine ( figs. 3 and 4) . In all cases the rhythm returned to sinus rhythm as the effect of the isoetharine waned. The appearance of nodal origin of the conduction pathway seemed to occur only with the lower doses of isoetharine. In no cases were premature ventricular contractions seen.
DISCUSSION
Although bronchospasm under general anaesthesia is not common, nevertheless it does occasionally occur. When this happens, the treatment poses a real problem if certain sensitizing hydrocarbons are being used as the primary anaesthetic agent. When agents such as cyclopropane or halothane are being used, the intravenous administration of the common catecholamine bronchodilators adrenaline and/or isoprenaline can cause severe ventricular arrhythmias. A safe, potent, rapidly acting bronchodilator that could be administered intravenously under these circumstances would be of real benefit. Isoetharine seems to fit into this category.
Since this study was performed, isoetharine has been given once intravenously to an asthmatic patient who developed severe bronchospasm during halothane anaesthesia. In this instance, following the administration of isoetharine 0.5 mg to this patient, there was prompt relief of the bronchospasm without any noticeable cardiac arrhythmias. It is suggested that isoetharine, in an intravenous preparation, could be a valuable
TABLE III
Summary oj electrocardiographs changes produced by isoetharine administered during cyclopropane anaesthesia. addition to the range of drugs for use in the treatment of bronchospasm developing during anaesthesia.
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